EQUITY INVESTMENT - Schedule of other expense (income) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Dec. 18, 2025 |
Mar. 31, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Debt and Equity Securities, FV-NI [Line Items] | ||||
| Cash proceeds | $ 750.0 | $ 74.0 | ||
| Wella Distribution Rights | 58.0 | $ 0.0 | ||
| Wella Company | ||||
| Debt and Equity Securities, FV-NI [Line Items] | ||||
| Cash proceeds | $ 750.0 | 750.0 | ||
| Wella Distribution Rights | 58.0 | 58.0 | ||
| Total consideration | $ 808.0 | 808.0 | ||
| Wella investment carrying value | 1,003.0 | |||
| Transaction and other costs to sell | 6.9 | |||
| Loss on sale of Wella investment | $ (201.9) | $ (201.9) | ||
| X | ||||||||||
- Definition Disposal Group, Including Discontinued Operation, Consideration, Equity No definition available.
|
| X | ||||||||||
- Definition Equity Securities, FV-NI, Investment Carrying Value No definition available.
|
| X | ||||||||||
- Definition Equity Securities, FV-NI, Transaction And Other Costs To Sell No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of an equity method investment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|